A Comparative Analysis of Glycemic Metrics Derived From Three Continuous Glucose Monitoring Systems
Diabetes Care · 01.07.2025 · 48 (7) · 1213-1217
DOI: 10.2337/dc25-0129 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Diabetes Care, online erschienen am 08.04.2025. Verfasst von Guido Freckmann und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institut für Diabetes-Technologie, Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm, Ulm, Germany. Hauptthemen laut MEDLINE: Blood Glucose, Blood Glucose Self-Monitoring. Die Arbeit wurde bisher 71-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Roche Diabetes Care GmbH, Ascensia Diabetes Care Holdings AG, Diabetes Center Berne.
Abstract (Originalsprache)
OBJECTIVE This study analyzed the differences in continuous glucose monitoring (CGM)-derived metrics among three current-generation systems and evaluated their impact on therapeutic decision-making. RESEARCH DESIGN AND METHODS Twenty-three participants wore the FreeStyle Libre 3, Dexcom G7, and Medtronic Simplera CGM systems for 14 days in parallel. CGM metrics were calculated for each participant and CGM system separately. RESULTS The apparent glucose profile was influenced by the used CGM system, resulting in substantially different glycemic metrics among the three systems. Agreement between FreeStyle Libre 3 and Dexcom G7 was higher than with Medtronic Simplera, which showed lower glucose levels, on average. There were marked intraparticipant discrepancies that would have resulted in different therapeutic recommendations. CONCLUSIONS The CGM systems indicated discordant glycemic metrics, which should be considered in diabetes therapy. Different CGM systems should provide the same glucose readings and CGM-derived metrics when used by the same person.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institut für Diabetes-Technologie, Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm, Ulm, Germany.
- Diabetes Center Berne, Berne, Switzerland.
ORCID-Profile: Guido Freckmann, Manuel Eichenlaub, Stefan Pleus, Delia Waldenmaier
Förderung
- Roche Diabetes Care GmbH
- Ascensia Diabetes Care Holdings AG
- Diabetes Center Berne
- BIONIME Corporation
- i-SENS, Inc.
Zitieren
APA
Freckmann, G., Wehrstedt, S., Eichenlaub, M., Pleus, S., Link, M., Jendrike, N., Öter, S., Brandt, D., Haug, C., & Waldenmaier, D. (2025). A Comparative Analysis of Glycemic Metrics Derived From Three Continuous Glucose Monitoring Systems. Diabetes Care, 48(7), 1213-1217. https://doi.org/10.2337/dc25-0129
Vancouver
Freckmann G, Wehrstedt S, Eichenlaub M, Pleus S, Link M, Jendrike N, et al. A Comparative Analysis of Glycemic Metrics Derived From Three Continuous Glucose Monitoring Systems. Diabetes Care. 2025;48(7):1213-1217. doi:10.2337/dc25-0129
BibTeX
@article{Freckmann2025,
author = {Freckmann, Guido and Wehrstedt, Stephanie and Eichenlaub, Manuel and Pleus, Stefan and Link, Manuela and Jendrike, Nina and Öter, Sükrü and Brandt, Derek and Haug, Cornelia and Waldenmaier, Delia},
title = {A Comparative Analysis of Glycemic Metrics Derived From Three Continuous Glucose Monitoring Systems},
journal = {Diabetes Care},
year = {2025},
volume = {48},
number = {7},
pages = {1213--1217},
doi = {10.2337/dc25-0129}
}
EUVIMED